Orchid Pharma Limited (BOM:524372)
India · Delayed Price · Currency is INR 710.00
-2.40 (-0.34%)
At close: Jul 25, 2025
Orchid Pharma Revenue
In the fiscal year ending March 31, 2025, Orchid Pharma had annual revenue of 9.22B INR with 12.52% growth. Orchid Pharma had revenue of 2.37B in the quarter ending March 31, 2025, with 9.39% growth.
Revenue
9.22B
Revenue Growth
+12.52%
P/S Ratio
3.91
Revenue / Employee
10.58M
Employees
871
Market Cap
36.03B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,765.41B |
| HDFC Bank | 2,736.06B |
| Bharti Airtel | 1,729.85B |
| Tata Consultancy Services | 2,561.48B |
| ICICI Bank | 2,054.85B |
| State Bank of India | 3,429.39B |
| Infosys | 1,672.76B |
| Bajaj Finance | 370.20B |
Orchid Pharma News
- 2 months ago - Orchid Pharma shares drop nearly 5% as Q4 net profit falls 32.4% YoY to Rs 22.3 crore - Business Upturn
- 5 months ago - Orchid Pharma shares surge 4.4% after successful USFDA inspection at Alathur API facility - Business Upturn
- 5 months ago - Orchid Pharma successfully completes USFDA inspection at Alathur API facility, secures EU GMP certification renewal - Business Upturn
- 5 months ago - Orchid Pharma shares drop over 14% as net profit falls 25.63% YoY to ₹22.45 crore in Q3 - Business Upturn
- 9 months ago - Orchid Pharma shares jump nearly 4% following strong Q2 FY25 results - Business Upturn
- 9 months ago - Orchid Pharma Q2 FY25 Results: Revenue jumps 12% to ₹222.7 crore, PAT up 26% YoY - Business Upturn